Sanan Pain Relief Oil India: Complete Guide to Vijaya Extract for Natural Pain Management

Sanan relief has become one of the most searched phrases among Indians living with chronic joint pain, sports injuries, and post-workout muscle soreness — and for good reason. Vijaya extract, the Ayurvedic name for full-spectrum cannabis leaf extract, has been used in Indian traditional medicine for over four thousand years to ease discomfort, reduce swelling, and restore mobility. Sanan Pain Relief Oil brings this ancient wisdom into a modern, GMP-certified formulation: a 50ml topical oil combining 4% Vijaya (Cannabis Sativa) leaf extract with camphor, ajwain, eucalyptus, turmeric, and boswellia. Available now on THC Store starting at ₹1,019, it represents one of the most complete Ayurvedic pain relief options currently accessible to Indian consumers without international sourcing hassles.

What Is Sanan Relief? Understanding Sanan Ayurvedics' Pain Management Line

Sanan Ayurvedics is the consumer-facing brand of Mehta Ayurvedic Sansthan, a family-run manufacturing house established in 1986 in Rajasthan. With nearly four decades of classical Ayurvedic production experience, Sanan entered the Vijaya extract space with GMP-certified, Ministry of AYUSH-licensed formulations that bridge traditional shastra-based preparation methods and modern pharmaceutical standards.

The Sanan "relief" product ecosystem centers on pain management from two angles:

• External topicals — the Sanan Pain Relief Oil (50ml), designed for massage into affected joints, muscles, and inflamed areas. Uses transdermal absorption to deliver active cannabinoids and co-active Ayurvedic botanicals directly to the site of discomfort.
• Internal oral preparations — the Sanan Mewa Modak Vati gummies and classical Mewa Modak Vati tablets, which provide systemic endocannabinoid support for conditions with a broader inflammatory or neuropathic component.

Together, these form a topical-plus-systemic protocol that many Ayurvedic practitioners now recommend for conditions like osteoarthritis, sports injuries, menstrual cramps, and post-operative recovery. For guidance on which approach fits your specific condition, book a consultation with one of our panel Ayurvedic doctors.

Sanan Pain Relief Oil: Full Ingredient Profile & Why Each Component Matters

Sanan's topical is not a simple infused oil — it is a multi-botanical synergistic formulation. Each ingredient serves a validated Ayurvedic and evidence-informed function:

Ingredient	Sanskrit / Common Name	Primary Action	Mechanism
Cannabis Sativa Leaf Extract (4%)	Vijaya / Vijaya patra	Analgesic, anti-inflammatory, muscle relaxant	CB1/CB2 receptor modulation; TRPV1 desensitization; COX-2 downregulation
Camphor	Karpura	Counter-irritant, cooling sensation	TRPM8 activation creates "cold" signal that overrides pain (gate control theory)
Ajwain (Carom seeds)	Ajmoda	Anti-spasmodic, warming	Thymol (active compound) relaxes smooth muscle, improves blood flow to the area
Eucalyptus Oil	Tailaparna	Penetration enhancer, anti-inflammatory	1,8-cineole enhances skin permeability for co-active compounds; anti-inflammatory via NF-κB inhibition
Turmeric (Curcuma longa)	Haridra	Anti-inflammatory, antioxidant	Curcumin inhibits TNF-α and IL-6; synergizes with cannabinoids on joint inflammation
Clove (Syzygium aromaticum)	Lavanga	Local analgesic, antiseptic	Eugenol acts as a local anesthetic; sodium channel blockade similar to benzocaine
Boswellia (Shallaki)	Shallaki	Anti-arthritic, leukotriene inhibitor	AKBA (boswellic acid) selectively blocks 5-LOX, reducing leukotriene production in joints; clinically validated for osteoarthritis

The synergy between Vijaya extract and boswellia is particularly notable: cannabinoids address the COX pathway while boswellic acids address the LOX pathway — providing dual blockade of the two major arachidonic acid cascades that drive joint inflammation. This dual-pathway approach is consistent with recommendations from integrative medicine practitioners who work with Vijaya extract in India today.

The Science: How Vijaya Extract Relieves Pain Through the Endocannabinoid System

The endocannabinoid system (ECS) is a regulatory network of receptors, endogenous ligands, and enzymes distributed throughout the central and peripheral nervous system, immune tissue, and skin. It is the body's primary pain modulation infrastructure. The two major receptors — CB1 (concentrated in the brain and spinal cord) and CB2 (concentrated in immune cells and peripheral tissue) — are activated by both endogenous cannabinoids (anandamide, 2-AG) and by phytocannabinoids like those found in Vijaya leaf extract.

When applied topically, Vijaya extract compounds interact with CB2 receptors in the skin and underlying tissue — triggering anti-inflammatory and analgesic cascades without reaching the brain at significant concentrations. This is why topical formulations like Sanan Pain Relief Oil do not produce psychoactive effects, yet can still provide meaningful local pain relief. Research published in Pharmaceuticals (Casedas et al., 2024) analysing 40 studies confirmed that cannabidiol — a primary constituent of full-spectrum Vijaya extract — reduces inflammatory mediators via TRPV-1 receptor activation, 5HT-1A modulation, and CB1 allosteric pathways, demonstrating both analgesic and anti-inflammatory properties across osteoarthritis, neuropathic pain, and post-operative pain models.

Importantly, topical cannabinoid products also interact with TRPV1 (transient receptor potential vanilloid-1) channels in skin nerve endings — the same receptors activated by capsaicin. TRPV1 overstimulation causes these pain-signalling nerve endings to become temporarily less sensitive (a process called desensitization), providing what clinicians describe as extended-duration pain relief that outlasts the product's local presence in the skin.

For conditions with a systemic inflammatory component — such as rheumatoid arthritis or ankylosing spondylitis — consider pairing topical Sanan Relief Oil with an oral Vijaya formulation after consulting one of our panel doctors. Explore our full Vijaya extract category for systemic options.

Clinical Evidence: What 2024–2025 Research Tells Us About Cannabis Pain Relief

The evidence base for cannabis-based pain relief has matured substantially in the last two years. Here are the most relevant findings for Indian consumers considering Sanan relief products:

Study 1 — Phase 3 RCT on Chronic Lower Back Pain (Nature Medicine, 2025)

A rigorous Phase 3 randomised controlled trial (VER-01) involving 820 patients with chronic low back pain found that full-spectrum cannabis extract (standardised to 2.5 mg THC, CBD, and CBG per dose) produced statistically significant improvements in pain intensity scores, sleep quality, physical function, and quality of life compared to placebo. Patients with a neuropathic component — where conventional NSAIDs typically fail — showed the most pronounced benefit. Adverse events were mild-to-moderate and consistent across treatment groups. (Bimonte et al., Nature Medicine, 2025)

Study 2 — Vijaya Extract for Cancer Pain in India (Journal of Population Therapeutics and Clinical Pharmacology, 2025)

In an India-specific pilot study, Pandey et al. administered sublingual Vijaya extract (Cannabryl full-spectrum) to 20 palliative cancer patients over 30 days. Researchers observed significant improvement in pain scores alongside favorable trends in dopamine and serotonin markers — with no serious adverse effects. The study concluded that Vijaya Extract is "an effective adjuvant therapy for pain management in palliative cancer care", offering particular value when opioid dose reduction is clinically desirable. (Pandey et al., JPTCP, 2025)

Study 3 — CBD Systematic Review: 40 Studies Across Multiple Pain Types (Pharmaceuticals, 2024)

Casedas, de Yarza-Sancho, and Lopez conducted a systematic review of 40 studies on CBD as an analgesic — including 11 human clinical trials spanning osteoarthritis, neuropathic pain, peripheral neuropathy, rheumatoid arthritis, and post-operative pain. They concluded that "CBD is an effective and safe treatment in reducing pain due to its analgesic and anti-inflammatory properties", operating through TRPV-1, 5HT-1A, and CB1 receptor pathways. (Casedas et al., Pharmaceuticals 17(11), 2024)

Study 4 — AHRQ Living Systematic Review on Cannabis for Chronic Pain (2025 Update)

The Agency for Healthcare Research and Quality (AHRQ) maintains an ongoing living systematic review aggregating all trial evidence on cannabis and plant-based treatments for chronic pain. The 2025 update consistently shows moderate evidence supporting cannabinoid use for neuropathic and musculoskeletal pain, with the strongest evidence in conditions where conventional analgesics have failed or caused adverse effects. (NCBI Bookshelf NBK618042)

Study 5 — Cannabis-Based Products for Chronic Pain: Updated Systematic Review (Annals of Internal Medicine, 2025)

An updated systematic review in Annals of Internal Medicine examined cannabis-based products across multiple chronic pain conditions, confirming clinically meaningful pain reduction in a significant proportion of patients and reinforcing the safety profile of low-dose, standardized preparations. (Annals of Internal Medicine, 179(2), 2025)

If you would like to explore whether clinical research on cannabis pain relief applies to your specific condition, speak with a qualified doctor on our platform — they can help you understand the evidence and design a personalized protocol.

Is Sanan Relief Legal in India? NDPS Act, AYUSH & Prescription Requirements

Understanding the legal status of Sanan's products is essential for confident purchasing. Here is the regulatory picture as of 2026:

The NDPS Act foundation: India's Narcotic Drugs and Psychotropic Substances Act, 1985 prohibits ganja (the flowering tops and resin of the cannabis plant) but explicitly excludes leaves and seeds of Cannabis Sativa from its definition of prohibited substances. Vijaya leaf extract — derived from the leaves, not flowers or resin — therefore falls outside the NDPS prohibition. This is the legal foundation on which all Sanan Ayurvedic products operate. For a full breakdown, see our NDPS Act edibles guide and THC gummies legal guide.

AYUSH Ministry licensing: In 2018, the Ministry of AYUSH formally permitted the use of Vijaya (cannabis) in classical Ayurvedic, Siddha, and Unani formulations. Sanan Ayurvedics holds the required GMP certification and AYUSH manufacturing license. Products listed under Schedule E-1 of the Drugs and Cosmetics Act — which includes many classical cannabis preparations — require prescription from a registered Ayurvedic practitioner. Sanan's Pain Relief Oil (topical, external use only) has a more accessible regulatory status than internal preparations.

Delhi High Court 2026 directive: In a landmark development, the Delhi High Court has directed the Union Government to consult scientific, medical, and civil society stakeholders to evaluate whether NDPS Act restrictions should be relaxed — with a formal policy decision expected by mid-2026. This signals a maturing regulatory environment that may expand the legal landscape for cannabis therapeutics in India over the coming years.

Purchasing guidance: To purchase Vijaya extract products with confidence, always buy from licensed, AYUSH-licensed platforms like THC Store. For products requiring a prescription under Schedule E-1, our panel doctors can issue prescriptions online after a consultation. See also: What is Vijaya Extract?

Who Should Consider Sanan Relief Products? Conditions & Use Cases

Based on clinical literature, traditional Ayurvedic indications, and real-world feedback from Indian consumers, Sanan relief products are most commonly used for:

• Chronic joint pain & osteoarthritis: The combination of Vijaya extract and boswellia provides dual LOX/COX anti-inflammatory blockade — especially relevant for knee, hip, and finger joint pain common in Indians over 45. See also: CBD for inflammation in India.
• Sports injuries & post-workout recovery: Athletes and gym-goers increasingly use topical Vijaya formulations for DOMS (delayed-onset muscle soreness), sprains, and repetitive strain injuries. Sanan Relief Oil's eucalyptus penetration-enhancer base makes it particularly effective for deep tissue application.
• Lower back pain: India's most prevalent musculoskeletal complaint. The Phase 3 VER-01 trial specifically demonstrated cannabis extract efficacy for chronic lower back pain — the condition Sanan Pain Relief Oil is most commonly marketed for.
• Headaches & migraines: Topical application to the temples and neck has been reported by users and is supported by CB1 receptor activity in cranial tissue. See our dedicated guide: CBD for migraine in India.
• Menstrual cramps: Smooth muscle relaxation via cannabinoid-ECS interaction and ajwain anti-spasmodic action makes the oil a candidate for abdominal application during dysmenorrhea.
• Arthritis in the hands: The oil's formulation penetrates joint tissue effectively; boswellia's specific action on the leukotriene pathway makes it particularly suited for inflammatory arthropathies.
• Neuropathic tingling: TRPV1 desensitization from cannabinoid application may help with peripheral neuropathy-associated burning or shooting sensations in the extremities.

If your pain is severe, persistent, or accompanies systemic symptoms (fever, weight loss, night sweats), please consult a doctor before relying on topical management alone.

How to Use Sanan Pain Relief Oil: Application, Dosage & Safety

Sanan's recommended usage protocol for the Pain Relief Oil:

1. Warm the oil: Pour 3-5 drops into clean palms and rub hands together for 10-15 seconds. Warming activates the volatile compounds (camphor, eucalyptus, ajwain) and enhances skin penetration.
2. Apply to affected area: Using firm circular motions, massage deeply into the joint, muscle group, or area of discomfort. Apply enough pressure to work the oil below the skin's surface layer.
3. Duration: Massage for 3-5 minutes per area. Allow 15-20 minutes for transdermal absorption before contact with clothing or water.
4. Frequency: 2-3 times daily, or as directed by your Ayurvedic practitioner. For acute injuries, up to 4 applications per day during the first 48-72 hours.
5. Avoid: Open wounds, broken skin, mucous membranes, eyes. External use only. Keep out of reach of children.
6. Storage: Store in a cool, dry place away from direct sunlight. Cap tightly between uses to prevent volatile compound evaporation.

Onset timeline: Most users report initial warming/cooling sensation within 2-4 minutes of application (from camphor + eucalyptus interaction). Deeper anti-inflammatory relief from Vijaya extract and boswellia typically becomes perceptible within 15-30 minutes of application and may be sustained for 4-6 hours. For chronic conditions, consistent use over 4-6 weeks produces cumulative benefit as the ECS baseline modulates.

Drug interactions & contraindications: Topical Vijaya extract products have minimal systemic absorption and thus lower interaction risk than oral preparations. However, if you are on blood thinners, immunosuppressants, or have a known sensitivity to any botanical constituent (especially camphor, ajwain, or eugenol/clove), please check with your doctor or book a consultation before use.

Sanan Relief vs. Other Cannabis Pain Products in India: Full Comparison

How does Sanan Pain Relief Oil stack up against other popular cannabis-based pain products available on THC Store? Here is an objective comparison to help you make an informed choice:

Product	Format	Key Ingredient	Best For	Price (THC Store)	Onset
Sanan Pain Relief Oil 50ml	Topical oil	Vijaya extract 4% + Boswellia, Camphor, Turmeric	Joint pain, back pain, sports injuries	₹1,019	2-4 min topical; 15-30 min deep relief
Cannabliss Arthritis Relief 50ml	Topical spray/oil	CBD isolate + herbal extracts	Arthritis-specific; inflammatory joint disease	₹849	15-30 min
Athletic Care Muscle Recovery 10ml	Targeted roll-on	CBD + sports recovery botanicals	Post-exercise soreness, DOMS, sprains	₹424	10-20 min
Go-Cramp Menstrual Pain Relief 50ml	Spray	Hemp extract + antispasmodic herbs	Dysmenorrhea, lower abdominal cramping	₹1,274	5-10 min
Sanan Mewa Modak Vati Gummies	Oral edible	Vijaya extract 350mg per gummy	Systemic pain, neuropathic pain, sleep disruption from pain	₹1,499	45-90 min (oral)
LITE 3500mg Calm & Anxiety Oil	Oral tincture	3500mg full-spectrum CBD	Pain from anxiety/stress; sleep-related pain amplification	₹2,124	15-45 min (sublingual)

Verdict: For localised joint and muscle pain, Sanan Pain Relief Oil is the strongest multi-botanical topical option in the Indian market — its boswellia + Vijaya combination is clinically superior to single-compound alternatives. For neuropathic or systemic pain, consider combining it with the Sanan Mewa Modak Vati oral preparation under medical supervision. Not sure which approach is right for you? Our doctors can help you decide.

Where to Buy Sanan Relief Oil Online in India

Sanan Pain Relief Oil (50ml) is available on THC Store at ₹1,019, with free shipping on orders above a qualifying threshold. THC Store is India's AYUSH-licensed cannabis wellness platform — all products listed are GMP-certified, third-party tested, and sourced directly from licensed manufacturers. You can browse the full Vijaya extract product range on the platform.

Benefits of purchasing through THC Store vs. general e-commerce platforms:

• Every product is verified for AYUSH compliance and GMP certification before listing
• Access to licensed doctor consultations for prescription-required products
• Comprehensive lab reports and batch certificates available on request
• Dedicated customer care team with cannabis-specific expertise
• Discreet, secure packaging with tamper-evident seals

If you need a prescription for any Schedule E-1 Ayurvedic preparation, book a consultation with our panel Ayurvedic doctors — teleconsultations are available across India, and most prescriptions are issued within 24 hours.

Other Sanan Ayurvedic Products for Pain & Whole-Body Wellness

Beyond the Pain Relief Oil, Sanan Ayurvedics offers a range of classical Vijaya extract preparations that complement a comprehensive pain management protocol:

• Sanan Mewa Modak Vati Cannabis Gummies — 10,500mg Vijaya extract in a 30-piece gummy formulation; ideal for systemic anti-inflammatory support and pain that disrupts sleep.
• Sanan Ayurvedic Mewa Modak Vati tablets — classical tablet preparation following Charaka Samhita formulation guidelines; traditionally used for Vata-type joint conditions.
• Sanan Bilwadi Churan Tablets (500mg) — digestive-supportive Vijaya formulation; particularly useful when chronic pain coexists with IBS, digestive inflammation, or stress-induced gut dysfunction.
• Cannarma Trailokya Vijaya Vati — another classical Ayurvedic Vijaya preparation, available alongside Sanan products; see our cannabis edibles guide for a full comparison.

For conditions where pain management intersects with anxiety, poor sleep, or stress (which amplify pain perception significantly), explore our gummies and edibles collection for complementary oral Vijaya preparations.

Combining Topical Sanan Relief With Systemic Vijaya Support: A Holistic Protocol

Modern pain science increasingly supports multimodal approaches — combining local tissue-level intervention with systemic modulation of central pain sensitization. Sanan's product range supports exactly this:

1. Morning: Apply Sanan Pain Relief Oil to affected joints/muscles as part of morning movement or yoga routine. The warming botanicals (camphor, eucalyptus) are particularly effective at improving circulation and reducing morning stiffness.
2. Evening: Consider an oral Vijaya preparation (Mewa Modak Vati or tincture) 45-60 minutes before bed to address systemic inflammation and improve sleep quality — both of which are critical for pain recovery. Poor sleep amplifies pain perception by up to 50%, so improving sleep is itself an analgesic intervention.
3. Acute flare: Increase topical application frequency to 3-4x/day; apply immediately post ice-therapy to improve tissue penetration while blood vessels are constricting.
4. Maintenance: Once baseline pain improves (typically 4-6 weeks of consistent use), many practitioners recommend once-daily topical application and oral Vijaya 3-4 nights per week as maintenance.

This protocol should be designed with a qualified practitioner. Book a teleconsultation with our Ayurvedic doctors to create a personalized pain management plan using Sanan products as a foundation.

Frequently Asked Questions About Sanan Relief

Can I use Sanan Pain Relief Oil every day?

Yes. Sanan Pain Relief Oil is designed for daily use — 2-3 times per day for chronic conditions, and up to 4 applications daily during acute flares. Long-term daily topical use of Vijaya extract has not been associated with tolerance development or adverse effects in current literature. Unlike oral NSAIDs, topical formulations do not accumulate systemically and do not carry the GI, cardiovascular, or renal risks associated with chronic NSAID use. If you are using it daily for a condition that persists beyond 8-10 weeks without improvement, consult a doctor to rule out underlying pathology.

Will Sanan Pain Relief Oil make me high or appear on a drug test?

No. Topical cannabis products do not produce psychoactive effects because they do not reach the bloodstream at concentrations sufficient for CNS activity. Regarding drug tests: because transdermal absorption is minimal, topical Vijaya products are extremely unlikely to trigger a positive result on standard workplace urine screenings. However, if you are subject to zero-tolerance drug testing policies, consult our doctors for guidance on product selection and timing.

Is Sanan Relief legal to buy online in India without a prescription?

Sanan Pain Relief Oil (topical, external use only) is a Vijaya leaf extract product that falls within the NDPS Act's leaf exemption — making it legally accessible without requiring the Schedule E-1 prescription that applies to internal cannabis preparations. You can purchase it directly on THC Store. For Sanan's internal oral preparations (Mewa Modak Vati tablets), a prescription from an AYUSH-registered practitioner is recommended; our online consultation service facilitates this. For full details, see our legal guide to cannabis edibles in India.

How long does Sanan Pain Relief Oil take to work?

The warming/cooling sensation from camphor and eucalyptus is typically perceptible within 2-4 minutes of application — this phase primarily represents counter-irritant activity and improved local circulation. Deeper anti-inflammatory relief from the Vijaya extract and boswellia interaction typically becomes noticeable within 15-30 minutes. For chronic conditions (osteoarthritis, chronic back pain), cumulative anti-inflammatory benefit builds over 2-4 weeks of consistent use, with most users reporting meaningful reduction in baseline discomfort by the 4-week mark.

Can I use Sanan Relief Oil alongside other medications?

Topical Vijaya extract products are generally considered compatible with oral medications because systemic absorption is minimal. However, if you are taking blood thinners (warfarin, aspirin), corticosteroids, or immunosuppressants, or if you have a known allergy to any botanical in the formulation (camphor, eucalyptus, clove/eugenol, turmeric, boswellia, ajwain), consult your doctor before use. Our panel physicians are available online and can review your current medication list before you purchase.

What is the difference between Sanan Mewa Modak Vati and Sanan Pain Relief Oil?

They address pain through different mechanisms and routes of administration. The Sanan Mewa Modak Vati is an oral preparation absorbed through the digestive system — it provides systemic endocannabinoid support for conditions with a widespread inflammatory or neuropathic component. The Pain Relief Oil is a topical formulation that works locally at the application site via transdermal cannabinoid absorption. For maximum effect with severe or widespread pain, many practitioners recommend using both concurrently. See our Mewa Modak Vati guide for detailed oral dosing guidance.

Are there any side effects from Sanan Relief Oil?

Side effects from topical Vijaya extract products are uncommon. Potential mild reactions include: temporary skin redness or warmth at the application site (usually from camphor's counter-irritant effect — this is expected and typically subsides within 30 minutes); mild tingling; and in rare cases, contact sensitivity to one of the botanical constituents. Perform a patch test on a small skin area for 24 hours before first full application if you have sensitive skin. Avoid contact with eyes and mucous membranes. If you experience significant rash, blistering, or prolonged skin reaction, discontinue use and consult a physician.

Sanan Ayurvedics: Brand Heritage & Quality Credentials

Understanding who makes Sanan Relief products helps you assess the quality and safety standards you are purchasing from. Mehta Ayurvedic Sansthan, founded in 1986, brings nearly four decades of classical Ayurvedic manufacturing expertise to the Vijaya extract space. Unlike newer startups entering the Indian cannabis market without manufacturing heritage, Sanan's parent entity has established relationships with Ayurvedic raw material suppliers, quality control laboratories, and regulatory bodies accumulated over decades.

Key quality credentials:

• GMP certification — manufacturing facility meets Good Manufacturing Practice standards as mandated by the Ministry of AYUSH
• AYUSH manufacturing license — formally permitted to produce Schedule E-1 Ayurvedic preparations including Vijaya extract formulations
• ISO certification — third-party quality management system certification
• Classical formulation basis — preparations referenced in classical Ayurvedic texts (Charaka Samhita, Sushruta Samhita) rather than novel arbitrary combinations

This heritage-plus-certification combination is relatively rare in India's cannabis supplement market, where many brands lack manufacturing lineage or AYUSH oversight. It is part of why THC Store has chosen to partner with Sanan as a featured vendor. Explore the full Vijaya extract range on THC Store, or learn more about what Vijaya extract is and why it is India's preferred legal cannabis formulation.

Conclusion: Is Sanan Relief Right for You?

Sanan Pain Relief Oil represents a genuinely sophisticated multi-botanical approach to cannabis-based pain management — one grounded in both classical Ayurvedic formulation principles and the emerging clinical evidence base for cannabinoid analgesics. For Indians living with chronic joint pain, sports-related musculoskeletal conditions, or inflammatory conditions where conventional NSAIDs have proven unsatisfactory or caused adverse effects, it offers a meaningful, legally compliant alternative.

The convergence of Vijaya extract, boswellia, turmeric, and camphor in a GMP-certified topical formulation addresses pain through at least five distinct mechanisms — making it therapeutically robust in a way that single-ingredient products cannot match. At ₹1,019 for a 50ml bottle with free shipping via THC Store, it is also competitively priced relative to imported CBD topicals.

Whether you are a first-time Vijaya extract user or looking to expand an existing supplement protocol, we recommend starting with the topical oil and assessing response over 4-6 weeks before adding systemic oral preparations. For chronic, severe, or complex pain conditions, please book a consultation with one of our panel doctors — they can help you design a protocol that is safe, legal, and evidence-informed.

Browse the full Vijaya extract range, explore our edibles and gummies collection, and learn more about cannabis edibles in India to build a complete wellness approach tailored to your needs.

Sources & References

1. Bimonte et al. (2025). Phase 3 randomised controlled trial: Full-spectrum cannabis extract (VER-01) for chronic lower back pain. Nature Medicine. https://www.nature.com/articles/s41591-025-03977-0
2. Pandey KK, Mishra PK, et al. (2025). Vijaya Extract (Cannabryl Full Spectrum) as adjuvant therapy for pain management in palliative cancer care: Pilot study. Journal of Population Therapeutics and Clinical Pharmacology, 32(8). http://jptcp.com/index.php/jptcp/article/view/12917
3. Casedas G, de Yarza-Sancho M, Lopez V. (2024). CBD as analgesic: Systematic review of 40 studies including 11 human clinical trials across osteoarthritis, neuropathic pain, and rheumatoid arthritis. Pharmaceuticals, 17(11), 1438. https://www.mdpi.com/1424-8247/17/11/1438
4. Agency for Healthcare Research and Quality (AHRQ). (2025 update). Living Systematic Review on Cannabis and Plant-Based Treatments for Chronic Pain. NCBI Bookshelf NBK618042. https://www.ncbi.nlm.nih.gov/books/NBK618042/
5. Annals of Internal Medicine. (2025). Updated systematic review: Cannabis-based products for chronic pain conditions. Annals of Internal Medicine, 179(2). https://www.acpjournals.org/doi/10.7326/ANNALS-25-03152